Moderna Inc at Piper Sandler Healthcare Conference Transcript
Hello, everyone. My name is Ted Tenthoff. I'm a senior biotech analyst at Piper Sandler. And before I begin our next presentation, I'm required to point out certain disclosures regarding the relationship between Piper and our next presenting company, Moderna, which are located both at the back of the room and also at the registration desk.
As you all probably are well familiar by this point, Moderna is the leading developer of Messenger RNA or mRNA vaccines and medicines. mRNA shares have been under significant pressure over the last 2 years with the waning of the COVID pandemic. It just shows you, you do a good turn and then everybody forgets you. However, we really believe the company is in the strongest position in its history with a strong balance sheet, fundamentally derisk technology and a late-stage clinical pipeline with several upcoming approvals over the next several years.
Here from Moderna is CFO, Jamey Mock. Jamey, thanks for being with us.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |